News
-
-
PRESS RELEASE
Irving Finalizes Yamagano-Noto Joint Venture Term Sheet with Newmont and Sumitomo
Irving Resources Inc. announces finalization of non-binding term sheet for joint venture with Newmont and Sumitomo over Yamagano and Noto properties, including initial diamond drilling exploration program -
PRESS RELEASE
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program
Moderna's mRNA-3705 selected for FDA's START pilot program to address rare diseases. The investigational mRNA therapeutic aims to treat methylmalonic acidemia due to MUT deficiency with innovative mRNA platform -
PRESS RELEASE
Allessenz Unveils Revolutionary 13100mg Five-Fold Active Collagen Peptide Beverage, leading a new trend in dietary health
Allessenz launches 13100mg Five-Fold Active Collagen Peptide Beverage, promising advanced anti-aging benefits with deep hydration, wrinkle reduction, and dual-action sugar control -
-
PRESS RELEASE
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference
Zomedica Corp. announces research confirming TRUFORMA's superiority in diagnosing feline hyperthyroidism compared to CLIA platforms. Dr. Camille Brassard presents results at ACVIM Forum 2024 -
PRESS RELEASE
HDBank, the 1st Vietnamese lender to disclose Sustainability Report and net-zero target
Ho Chi Minh City Development Joint Stock Commercial Bank (HDBank) releases Sustainability Report, committing to net-zero emissions. Report follows Global Reporting Initiative standards and emphasizes ESG strategies, objectives, and achievements -
-
PRESS RELEASE
INDUS successfully completes acquisition of British company COLSON X-Cel
INDUS Holding AG successfully completes the acquisition of British company COLSON X-Cel, enhancing its internationalization strategy and market presence. The acquisition expands INDUS's portfolio in the industrial engineering sector -
PRESS RELEASE
Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
Medios AG completes acquisition of Ceban, expanding market position in Europe. Ceban, a pharmaceutical compounding platform, adds strategic diversification and growth opportunities
